Pharmacokinetic profile data of glycopyrronium bromide 1% cream beyond 2 weeks are important: reply from the authors
| Autor: | C. Abels, M. Soeberdt, A. Kilic, H. Reich, U. Knie, C. Masur, R.‐M. Szeimies |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry Topical Product Dermatology Muscarinic Antagonists Axillary hyperhidrosis Glycopyrrolate 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Pharmacokinetics Administration Inhalation medicine Humans Glycopyrronium bromide business medicine.drug |
| Zdroj: | The British journal of dermatologyReferences. 185(2) |
| ISSN: | 1365-2133 |
| Popis: | Gregoriou et al ask for systemic PK data beyond 2 weeks following the topical application of glycopyrronium bromide (GPB) containing cream for treatment of primary axillary hyperhidrosis referring to another recently approved glycopyrronium tosylate (GPT) containing topical product. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text